Want to join the conversation?
$HOLX's total expenses rose 12.9% in 2Q16, mainly due to investments in breast health and diagnostic marketing programs. This spending increase will continue into 2H16. $HOLX spent $311.4MM in 2Q16 to repurchase convertible notes for $226.6MM. In 2Q16, company brought back 4.3MM shares for $148.8MM. Diluted shares outstanding was 288MM at end 2Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?